Role of hemodialysis in baclofen overdose with normal renal function.

Indian J Pharmacol

Department of Medicine, Kasturba Medical College, Manipal, Karnataka, India.

Published: November 2011

The treatment of baclofen overdose is primarily supportive. There have been case reports of hemodialysis being used in patients with chronic kidney disease with baclofen overdose. A case report of hemodialysis in a baclofen-overdose patient with normal renal function is presented. Review of literature has also been provided.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229794PMC
http://dx.doi.org/10.4103/0253-7613.89835DOI Listing

Publication Analysis

Top Keywords

baclofen overdose
12
normal renal
8
renal function
8
role hemodialysis
4
hemodialysis baclofen
4
overdose normal
4
function treatment
4
treatment baclofen
4
overdose supportive
4
supportive case
4

Similar Publications

Baclofen-related deaths in Australia 2000-2022.

Forensic Sci Int

December 2024

National Drug & Alcohol Research Centre, University of New South Wales, NSW 2052, Australia.

Article Synopsis
  • Baclofen, prescribed for muscle spasms in Australia, has been linked to 102 deaths from 2000-2022, with a majority involving intentional toxicity and a significant presence of mental health and substance use issues among victims.
  • The average age of those who died was about 45.6 years, with 51% being male, and 73.5% had documented mental health problems.
  • The study highlights the importance of caution in prescribing baclofen due to its potential for misuse, dependency, and overdose.
View Article and Find Full Text PDF

Case Presentation: A woman in her 70s was found unresponsive and brought to our hospital with respiratory distress, cardiomyopathy and volatile alternation between hypotension and hypertension. She was intubated and admitted to intensive care for supportive treatment of suspected baclofen overdose. She gradually recovered and was discharged 10 days after presentation.

View Article and Find Full Text PDF

Pharmacological Treatments for Methamphetamine Use Disorder: Current Status and Future Targets.

Subst Abuse Rehabil

August 2024

Department of Psychological Science, Northern Kentucky University, Highland Heights, KY, USA.

The illicit use of the psychostimulant methamphetamine (METH) is a major concern, with overdose deaths increasing substantially since the mid-2010s. One challenge to treating METH use disorder (MUD), as with other psychostimulant use disorders, is that there are no available pharmacotherapies that can reduce cravings and help individuals achieve abstinence. The purpose of the current review is to discuss the molecular targets that have been tested in assays measuring the physiological, the cognitive, and the reinforcing effects of METH in both animals and humans.

View Article and Find Full Text PDF

Objective: Intrathecal baclofen (ITB) pumps are commonly used in pediatric patients with cerebral palsy (CP) and medically refractory spasticity. However, catheter malfunction and associated risk factors are not well understood. The aim of this study was to examine potential risk factors for spinal catheter malfunction and characterize postoperative follow-up to understand the clinical consequences.

View Article and Find Full Text PDF

Background: Spasticity and dystonia are movement impairments that can occur in childhood-onset neurological disorders. Severely affected individuals can be treated with intrathecal baclofen (ITB). Concomitant use of ITB and opioids has been associated with central nervous system (CNS) depression.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!